American Association for Cancer Research
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
American Association for Cancer Research
Apr 18, 2024, 16:48 |
Blog
Libia Scheller: I am grateful as a friend, a researcher, and an entrepreneur... Thank you Marge for all you do
Libia Scheller, Global Head of Oncology- Cooperative Groups and Strategic Alliances at Bayer HealthCare, recently shared…
Apr 17, 2024, 00:45 |
Blog
Junior faculty are invited to apply for the 2024 Triple Negative Breast Cancer Foundation-AACR NextGen Grant for Transformative Cancer Research
American Association for Cancer Research shared a post on LinkedIn: "Junior faculty are invited to apply…
Apr 16, 2024, 13:31 |
Blog
Sarabjot Pabla: What an incredible opportunity it was to be part of AACR2024
Sarabjot Pabla, Head of Clinical and Research Bioinformatics at OmniSeq, shared on their LinkedIn: ''What…
Apr 16, 2024, 12:00 |
Blog
Daniel De Carvalho: It was an honour to chair the early cancer biology plenary session this year at AACR annual meeting
Daniel De Carvalho, Co-founder and Chief Scientific Officer at Adela and Professor at Princess Margaret…
Apr 16, 2024, 11:36 |
Insight
Piotr Wysocki: Rechallenge with anti-EGFR antibodies is a feasible and safe strategy in refractory metastatic colorectal cancer patients with RAS/BRAFwt ctDNA
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 16, 2024, 11:25 |
Drugs
Piotr Wysocki: Adjuvant olaparib improves outcomes of breast cancer patients with germinal BRCA1/2 mutations at the cost of slightly decreased quality of life
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 16, 2024, 01:52 |
Insight
,
Opinion
Angela Mastronuzzi: We investigated whether CAR T-cells directed towards the disialoganglioside GD2 can represent a potentially more effective treatment with reduced long-term side effects
Apr 15, 2024, 21:00 |
Blog
On the dangers of blood clots for people with cancer and what patients can do to lower their risk - AACR
American Association for Cancer Research shared on LinkedIn: "Oncologist Michael B. Streiff on the dangers of…
Apr 15, 2024, 12:26 |
Career
Kimberly Meza: I am so honored to be a 2024 American Association for Cancer Research Minority in Cancer Research Scholar awardee
Kimberly Meza, Pathobiology Doctoral Student at Brown University, shared a post on LinkedIn: ''I am…
Apr 15, 2024, 12:19 |
Blog
Wafik S. El-Deiry: As I leave San Diego, I am very encouraged by all the scientific progress, enthusiasm of young people
Wafik S. El-Deiry shared a post on LinkedIn: ''Headed back to east coast after an outstanding…
2
3
4
5
6
All:
146
Posts:
31 - 40
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube